Reviewer: YANG Xue-ning, Literature Co-worker: LIN Jun-tao. The Role of Bevacizumab in Patients with Resected Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 233-235. DOI: 10.12019/j.issn.1671-5144.2018.04.011
|
Citation:
|
Reviewer: YANG Xue-ning, Literature Co-worker: LIN Jun-tao. The Role of Bevacizumab in Patients with Resected Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 233-235. DOI: 10.12019/j.issn.1671-5144.2018.04.011
|
Reviewer: YANG Xue-ning, Literature Co-worker: LIN Jun-tao. The Role of Bevacizumab in Patients with Resected Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 233-235. DOI: 10.12019/j.issn.1671-5144.2018.04.011
|
Citation:
|
Reviewer: YANG Xue-ning, Literature Co-worker: LIN Jun-tao. The Role of Bevacizumab in Patients with Resected Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 233-235. DOI: 10.12019/j.issn.1671-5144.2018.04.011
|
DownLoad: